Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J01FA09
|
| gptkbp:brand |
gptkb:clarithromycin
|
| gptkbp:contraindication |
liver dysfunction
history of QT prolongation |
| gptkbp:discoveredIn |
1980s
|
| gptkbp:drugClass |
macrolide
|
| gptkbp:eliminationHalfLife |
3-7 hours
|
| gptkbp:form |
gptkb:tablet
oral suspension |
| gptkbp:genericName |
gptkb:clarithromycin
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biaxin
|
| gptkbp:interactsWith |
gptkb:warfarin
statins colchicine |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Abbott_Laboratories
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea abdominal pain taste disturbance |
| gptkbp:treatment |
gptkb:Helicobacter_pylori_infection
skin infections respiratory tract infections |
| gptkbp:usedFor |
bacterial infections
|
| gptkbp:bfsParent |
gptkb:clarithromycin
|
| gptkbp:bfsLayer |
6
|